This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WARFIELD M. FIROR, M.D.

Arch Surg. 1940;41(2):299-307.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The treatment of clinical tetanus is in an uncertain and unsatisfactory state. The mortality is high; there is no agreement as to the form of treatment that gives the best results, and the therapeutic use of antitoxin has not brought about an appreciable decrease in the death rate. The explanation commonly given for this therapeutic failure is that tetanus antitoxin cannot neutralize toxin which has become fixed by the tissues. It is impossible to verify this statement in human beings, but with dogs Abel and his associates have thrown some light on the fate of tetanus toxin in the body.¹ They have shown that up to a certain time one or more lethal doses of toxin which are apparently fixed can still be neutralized if considerable excess of antitoxin is given, but if administration of antitoxin is delayed for too long a time the fixed toxin is not susceptible . . . [Full Text PDF of this Article]

Author Affiliations
BALTIMORE

From the Surgical Hunterian Laboratory of the Johns Hopkins University.

Footnotes
This investigation was aided by a grant from the John and Mary R. Markle Foundation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?